or Try an Advanced Search...

    Technical Analysis for BHC - Bausch Health Companies Inc.

    Grade Last Price % Change Price Change
    D 11.920 1.10% 0.130
    BHC closed up 1.1 percent on Friday, April 26, 2024, on 45 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    Earnings due: May 2
    *** please verify all earnings dates ***
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Up Down Up
    Historical BHC trend table...
    Date Alert Name Type % Chg
    Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
    Stochastic Buy Signal Bullish 1.10%
    Narrow Range Bar Range Contraction 1.10%
    Outside Day Range Expansion 1.10%
    Up 3 Days in a Row Strength 1.10%
    Oversold Stochastic Weakness 1.10%
    Boomer Buy Setup Bullish Swing Setup 1.62%
    NR7 Range Contraction 1.62%
    NR7-2 Range Contraction 1.62%
    Narrow Range Bar Range Contraction 1.62%
    Older End-of-Day Signals for BHC ...

       Recent Intraday Alerts

    Alert Time
    Up 2% about 6 hours ago
    Up 1% about 8 hours ago
    Rose Above Previous Day's High about 9 hours ago
    Rose Above 10 DMA about 9 hours ago
    Boomer Buy Entry 1 day ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    BHC Chart by TradingView
    Basic chart:

    Profile

    Bausch Health Companies Inc. Description

    Bausch Health Companies Inc, formerly Valeant Pharmaceuticals International Inc, is a Canada-based company that develops, manufactures and markets a range of branded and generic pharmaceuticals, medical devices and over-the-counter products. It primarily develops products in the therapeutic areas of eye health, gastroenterology and dermatology. Its dermatology products treat a range of conditions, including actinic keratosis, acne, atopic dermatitis, psoriasis and other dermatoses. It also offers a selection of aesthetic medical devices that address a variety of conditions, including facial wrinkles, acne, pigmentation conditions and laser hair removal, among others. The gastrointestinal (GI) segment offers products that treat GI and hepatologic conditions, including hepatic encephalopathy, irritable bowel syndrome with diarrhea and ulcerative colitis, among others. Its eye health products are marketed in the following categories: Contact Lens, Pharmaceutical Products and Surgical.

    Classification
    Sector: Healthcare
    Industry: Drug Manufacturers - Specialty & Generic
    Keywords: Health S&P/Tsx 60 Index Medicine Pharma Pharmaceutical Biotechnology Pharmaceuticals Pharmaceutical Products Laser Medical Devices Contact Lens Ulcer Aes Dermatology Psoriasis Acne Actinic Keratosis Atopic Dermatitis Colitis Hair Removal Keratosis Over The Counter Products Specialty Drugs Ulcerative Colitis

    Is BHC a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 3 bullish, 2 bearish and 0 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 25 Earnings Preview: Alignment Healthcare (ALHC) Q1 Earnings Expected to Decline
    Apr 24 Analysts Estimate Bausch + Lomb (BLCO) to Report a Decline in Earnings: What to Look Out for
    Apr 23 Bausch Health in 'Stronger Position' for Bausch + Lomb Distribution, RBC Says
    Apr 20 10 Best Healthcare Stocks to Buy Under $20
    Apr 11 Bausch Health to Announce First-Quarter 2024 Results on May 2
    Apr 11 Court of Appeals for the Federal Circuit Issues Ruling in Norwich Case that Prevents FDA Approval of Norwich’s Abbreviated New Drug Application Until 2029
    Apr 11 Bausch wins US appeal to block Alvogen generic of diarrhea drug
    Apr 11 Acne Vulgaris Treatment PrARAZLO(TM) (Tazarotene Lotion, 0.045%) Now Available to Patients Through British Columbia PharmaCare Public Drug Plan
    Apr 8 CANADA STOCKS-TSX ends flat as gold stocks drop, mood cautious ahead of rate decision
    Apr 8 Bausch (BHC) Starts Litigation Against Amneal for Xifaxan
    See more BHC news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 15.43
    52 Week Low 7.56
    Average Volume 407,662
    200-Day Moving Average 11.232
    50-Day Moving Average 12.581
    20-Day Moving Average 12.497
    10-Day Moving Average 11.835
    Average True Range 0.510
    RSI (14) 42.53
    ADX 29.18
    +DI 26.550
    -DI 17.161
    Chandelier Exit (Long, 3 ATRs) 13.902
    Chandelier Exit (Short, 3 ATRs) 13.029
    Upper Bollinger Bands 14.229
    Lower Bollinger Band 10.765
    Percent B (%b) 0.33
    BandWidth 27.712
    MACD Line -0.297
    MACD Signal Line -0.212
    MACD Histogram -0.0847
    Fundamentals Value
    Market Cap 4.23 Billion
    Num Shares 355 Million
    EPS -2.61
    Price-to-Earnings (P/E) Ratio -4.57
    Price-to-Sales 0.84
    Price-to-Book 11.59
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 12.415
    Resistance 3 (R3) 12.403 12.227 12.333
    Resistance 2 (R2) 12.227 12.101 12.233 12.305
    Resistance 1 (R1) 12.073 12.023 12.150 12.085 12.277
    Pivot Point 11.897 11.897 11.935 11.903 11.897
    Support 1 (S1) 11.743 11.771 11.820 11.755 11.563
    Support 2 (S2) 11.567 11.693 11.573 11.535
    Support 3 (S3) 11.413 11.567 11.508
    Support 4 (S4) 11.425